Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: findings from an open-label treatment extension.

Ruperto N;Lovell DJ;Cuttica R;Woo P;Meiorin S;Wouters C;Silverman ED;Balogh Z;Henrickson M;Davidson J;Foeldvari I;Imundo L;Simonini G;Oppermann J;Xu S;Shen YK;Visvanathan S;Fasanmade A;Mendelsohn A;MARTINI, ALBERTO;Giannini EH

2010-01-01